Providence Therapeutics Company

Providence Therapeutics is a biotechnology company that develops a personalized mRNA cancer vaccine designed to treat ovarian cancer.
Technology: RNA
Industry: RNA
Headquarters: Toronto, Ontario, Canada
Founded Date: 2015-01-01
Employees Number: 11-50
Investors Number: 1
Total Funding: 149500000
Last Funding Date: 2021-12-07
Last Funding Type: Grant

Visit Website
Register and Claim Ownership